Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01766440 · ClinicalTrials.gov registry record · Phase 4
PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 18
- Enrollment target
NCT01766440 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 18 participants.
The verdict
NCT01766440, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 18 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the calcitriol absorption in pediatric subjects is comparable to that in adults and adolescents, with no significant impact on calcium/phosphorus metabolism.
Interventions
- DRUG Calcitriol 3 mcg/g ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2013-03 |
| Est. Completion | 2015-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01766440
The ClinicalTrials.gov registry entry for NCT01766440 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Calcitriol 3 mcg/g ointment is the first listed.
NCT01766440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01766440 about?
NCT01766440 is a clinical study titled "PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis". The purpose of this study is to determine if the calcitriol absorption in pediatric subjects is comparable to that in adults and adolescents, with no significant impact on calcium/phosphorus metabolism.
What is the current status of trial NCT01766440?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 18 participants. The study started on 2013-03. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01766440?
The interventions under investigation include: Calcitriol 3 mcg/g ointment (DRUG).
Who is sponsoring clinical trial NCT01766440?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.